Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paracetamol pharmacokinetics before and after Roux-en-Y gastric bypass
NL-OMON48508Phase 4Withdrawn
- Sponsor
- Albert Schweitzer Hospital
- Start
- May 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of acetaminophen, sponsored by Albert Schweitzer Hospital. Primary endpoint: Pharmacokinetics of paracetamol and metabolites. Planned start May 2019; status: withdrawn.
02
Drugs
acetaminophen
Beyond the preview
Go deeper on NL-OMON48508.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON48508.